D L Murphy

814 total citations
16 papers, 640 citations indexed

About

D L Murphy is a scholar working on Behavioral Neuroscience, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, D L Murphy has authored 16 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Behavioral Neuroscience, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Social Psychology. Recurrent topics in D L Murphy's work include Stress Responses and Cortisol (7 papers), Neuroendocrine regulation and behavior (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). D L Murphy is often cited by papers focused on Stress Responses and Cortisol (7 papers), Neuroendocrine regulation and behavior (4 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). D L Murphy collaborates with scholars based in United States and United Kingdom. D L Murphy's co-authors include B. Costall, James W. Smythe, Seema Bhatnagar, James Hill, Katalin Szemeredi, György Bagdy, B. Kanyicska, J Powell-Tuck, Caroline Archer and Charanjit S. Aulakh and has published in prestigious journals such as American Journal of Psychiatry, Gut and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

D L Murphy

16 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D L Murphy United States 12 267 202 150 109 105 16 640
Sally M. Anderson United States 14 234 0.9× 201 1.0× 106 0.7× 106 1.0× 60 0.6× 19 1.1k
Anna H. V. Söderpalm United States 11 169 0.6× 307 1.5× 112 0.7× 49 0.4× 43 0.4× 12 618
Ryoko Hiroi United States 17 357 1.3× 200 1.0× 237 1.6× 128 1.2× 209 2.0× 24 959
Melanie Pecins-Thompson United States 10 315 1.2× 172 0.9× 202 1.3× 91 0.8× 273 2.6× 12 829
Karen L. French United Kingdom 11 293 1.1× 117 0.6× 144 1.0× 87 0.8× 178 1.7× 12 719
Nicole H. Mutschler United States 12 239 0.9× 427 2.1× 194 1.3× 155 1.4× 40 0.4× 12 632
Tracy R. Butler United States 17 246 0.9× 409 2.0× 147 1.0× 144 1.3× 39 0.4× 26 852
K. T. Britton United States 10 399 1.5× 375 1.9× 209 1.4× 134 1.2× 83 0.8× 12 743
Courtney S. Vetter-O’Hagen United States 8 183 0.7× 236 1.2× 129 0.9× 67 0.6× 42 0.4× 8 466
Louis D. Van de Kar United States 8 298 1.1× 170 0.8× 220 1.5× 95 0.9× 66 0.6× 8 598

Countries citing papers authored by D L Murphy

Since Specialization
Citations

This map shows the geographic impact of D L Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D L Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D L Murphy more than expected).

Fields of papers citing papers by D L Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D L Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D L Murphy. The network helps show where D L Murphy may publish in the future.

Co-authorship network of co-authors of D L Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of D L Murphy. A scholar is included among the top collaborators of D L Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D L Murphy. D L Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Powell-Tuck, J, et al.. (1999). A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition. Gut. 45(1). 82–88. 90 indexed citations
2.
Murphy, D L, B. Costall, & James W. Smythe. (1998). Regulation of Hippocampal Theta Activity by Corticosterone: Opposing Functions of Mineralocorticoid and Glucocorticoid Receptors. Brain Research Bulletin. 45(6). 631–635. 20 indexed citations
3.
Smythe, James W., et al.. (1998). The Effects of Intrahippocampal Scopolamine Infusions on Anxiety in Rats as Measured by the Black–White Box Test. Brain Research Bulletin. 45(1). 89–93. 56 indexed citations
4.
Smythe, James W., et al.. (1997). Cognitive Dysfunctions Induced by Scopolamine Are Reduced by Systemic or Intrahippocampal Mineralocorticoid Receptor Blockade. Pharmacology Biochemistry and Behavior. 56(4). 613–621. 8 indexed citations
5.
Altemus, Margaret, et al.. (1997). Discussion. Neuropsychopharmacology. 17(2). 100–109. 70 indexed citations
6.
Smythe, James W., et al.. (1997). Hippocampal Mineralocorticoid, but Not Glucocorticoid, Receptors Modulate Anxiety-Like Behavior in Rats. Pharmacology Biochemistry and Behavior. 56(3). 507–513. 101 indexed citations
7.
Smythe, James W., D L Murphy, & B. Costall. (1996). Benzodiazepine Receptor Stimulation Blocks Scopolamine-Induced Learning Impairments in a Water Maze Task. Brain Research Bulletin. 41(5). 299–304. 13 indexed citations
8.
Smythe, James W., et al.. (1996). Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacology Biochemistry and Behavior. 54(1). 57–63. 71 indexed citations
9.
Aulakh, Charanjit S., Pascale Mazzola‐Pomietto, James Hill, & D L Murphy. (1994). Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats.. Journal of Pharmacology and Experimental Therapeutics. 271(1). 143–148. 9 indexed citations
10.
Aulakh, Charanjit S., Pascale Mazzola‐Pomietto, Kinga Woźniak, James Hill, & D L Murphy. (1994). Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.. Journal of Pharmacology and Experimental Therapeutics. 270(1). 127–132. 18 indexed citations
11.
Aulakh, Charanjit S., James Hill, Klaus‐Peter Lesch, & D L Murphy. (1992). Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain.. Journal of Pharmacology and Experimental Therapeutics. 262(3). 1038–1043. 27 indexed citations
12.
Pato, Michele T., James Hill, & D L Murphy. (1990). A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.. PubMed. 26(2). 211–4. 24 indexed citations
13.
Bagdy, György, Katalin Szemeredi, B. Kanyicska, & D L Murphy. (1989). Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 72–78. 62 indexed citations
14.
Siever, Larry J., et al.. (1984). Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. American Journal of Psychiatry. 141(6). 733–741. 58 indexed citations
15.
Siever, L.J., D. Pickar, C R Lake, et al.. (1983). Extreme elevations in plasma norepinephrine associated with decreased alpha-adrenergic responsiveness in major depressive disorder: two case reports.. PubMed. 3(1). 39–41. 10 indexed citations
16.
Murphy, D L. (1976). Effects of lithium on catecholamines and other brain neurotransmitters.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(2). 165–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026